News and Announcements
Diversified Crypto Fund Performs Substantially Better Than Many Crypto Portfolios
- Published July 28, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Boston Trading Co. is a diversified crypto fund (Bostoncoin) that provides easy access to crypto for individuals, retail investors and superannuation/SMSF’s/401K/RothIRA/retirement funds.
Investors have received returns of 366% per year on average for four years in a row, outperforming Bitcoin for six years. Since 2016, the Bostoncoin portfolio has included 30 to 50 crypto tokens plus tech stocks, making it easier for investors to have a safe and secure diversified crypto portfolio.
Portfolio Update
June 30th 2022
DART NAV 82.1310282
DART price 90.344131
One of the larger holdings in the DARTcoin portfolio is down massively; here is why Boston Trading is not panicking.
The Fund bought heavily into ThorChain (RUNE) when it was $0.50. It rocketed all the way up to $14 for almost 3000% gains. With the advent of crypto winter, RUNE has fallen to $1.85; losing almost 90% of its previous value, but the price is still 300% higher than when they first bought it. Boston Trading still has faith in the project and hopes to see it one day exceed its previous high.
The Bostoncoin diversified portfolio has fared better than many other crypto portfolios, due to its sensible diversification and lack of leverage. Whilst 3AC dropped 50-80% with Terra/Luna, Bostoncoin only slipped around 2.5%. The Fund continues to monitor the markets, rebalance as appropriate, and add to their positions when the price is low. Similar to grandaddy Bitcoin, the Bostoncoin portfolio is down for the year, but has more than doubled in the last two years.
Price updates for Bostoncoin, POLLYcoin, and DARTcoin will continue in the newsletters and the blog, and are also featured on mutual fund aggregation service Morningstar.
Until next time, do as the wealthy do: get good advice from a professional, think long-term, and be bold when others are afraid.
Company Updates
Cosmo Innovations Founder Eyes Global Rollout of SkinGate, IPO by 2027
Dr. Mathew Jafarzadeh, founder of Cosmo Innovations, is set to revolutionize the $65 billion home beauty tech market with SkinGate, a patented skincare infusion device. Following his presentation at Emergence 2025, he revealed plans for a global rollout, aiming for a 2027 IPO on NASDAQ or the Hong Kong Exchange. Discover how SkinGate, backed by 110+ patents, seeks to attract “smart capital” and redefine skincare delivery.
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!
In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]
Ecosystems Over Exit: Callum Laing on Disrupting Small Business M&A
At Emergence Singapore, Callum Laing of Veblen Director Program presented a bold new vision for small business M&A: “Ecosystems Over Exit.” He shared how his Unity Group takes cash-generating businesses public, focusing on growth over immediate founder exit. Discover his unique approach, how interconnected ecosystems drive massive deal flow, and a three-step framework for any business to amplify reach and capital raising.
Backed By Leading Investment Groups and Family Offices
